Avantium N.V (AVTX) | Stock Overview & Key Data

Avantium N.V. | Small-cap | Healthcare

€13.20

-5.67%

| Avantium N.V Stock Comparison:

Avantium N.V vs Pharming Group N.V Avantium N.V vs Vivoryon Avantium N.V vs Aegon Avantium N.V vs Galapagos NV Avantium N.V vs Koninklijke Philips Avantium N.V vs AEX Index | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Avantium N.V Performance Comparison

Loading chart data...

Avantium N.V

AEX Index

View Full Price History

Stock Range

Today's Range

Low: €13.03 High: €13.70

on June 17, 2025

52 Week Range

Low: €7.09 High: €29.35

on April 24, 2025

on October 21, 2024

All-Time High: €100.02 on March 13, 2017

Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights

Key Statistics

Market Cap i €117.8M

EPS i -3.60

P/E Ratio (TTM) i -36.67

Forward P/E i -26.94

P/B Ratio i 1.19

PEG Ratio i -26.94

Div. Yield i 0.00%

ROE i -43.03%

Beta i 1.257

Debt to Equity i 144.79

Financial Highlights

Profitability

Gross Margin i 72.28%

Operating Margin i -163.02%

Profit Margin i -127.72%

Returns and Earnings

Return on Assets (TTM) i -9.30%

Return on Equity (TTM) i -43.03%

EBITDA i €-36.0M

Net Income (TTM) i €-26.9M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Avantium N.V AVTX	117.79M Small-cap	-9.60%	18.40%	-23.35%	-26.14%	-30.85%	-46.34%	-49.02%	-76.69%
Pharming Group N.V PHARM	661.36M Mid-cap	-4.85%	15.29%	20.99%	15.29%	2.08%	31.08%	40.58%	-22.40%
Vivoryon VVY	42.80M Small-cap	-5.23%	-5.23%	-14.21%	-15.98%	-22.38%	-24.42%	-77.13%	-58.69%
Aegon AGN	9.89B Large-cap	-7.27%	-5.02%	-2.00%	2.09%	1.03%	6.16%	38.94%	136.47%
Galapagos NV GLPGA	1.67B Large-cap	2.03%	2.87%	5.11%	-2.33%	-8.59%	6.55%	-51.16%	-86.41%
Koninklijke Philips PHIA	18.40B Large-cap	-3.98%	-8.12%	-19.41%	-19.25%	-19.15%	-17.50%	0.25%	-51.55%

Ownership & Short Interest

Insider Ownership i 7.65%

Institutional Ownership i 5.65%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 173K

Average 90-Day Volume i 214K

Avantium N.V Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Avantium N.V would have performed over time.

Investment Amount

€

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is AVTX's 52-week high and low?

In the last 52 weeks, Avantium N.V reached a high of €29.35 (on October 21, 2024) and a low of €7.09 (on April 24, 2025).

What is the market cap and P/E ratio for AVTX?

Curious about Avantium N.V's size and valuation? Its market capitalization stands at 117.79M. When it comes to valuation, the P/E ratio (trailing twelve months) is -36.67, and the forward P/E (looking ahead) is -26.94.

Does AVTX pay dividends? If so, what's the yield?

As for dividends, Avantium N.V isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Avantium N.V's main competitors or similar companies to consider before investing?

When looking at Avantium N.V, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Pharming Group N.V PHARM	661.36M	Healthcare	Biotechnology	31.08%	40.58%
Vivoryon VVY	42.80M	Healthcare	Biotechnology	-24.42%	-77.13%
Aegon AGN	9.89B	Healthcare	Biotechnology	6.16%	38.94%
Galapagos NV GLPGA	1.67B	Healthcare	Biotechnology	6.55%	-51.16%
Koninklijke Philips PHIA	18.40B	Healthcare	Medical Devices	-17.50%	0.25%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Avantium N.V.? (e.g., ROE, Debt/Equity)

To get a sense of Avantium N.V's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -43.03%, the Debt to Equity ratio from the most recent quarter is 144.79, and its Gross Profit Margin stands at 72.28%.

What is the recent revenue and earnings growth for AVTX?

Looking at Avantium N.V's growth, its revenue over the trailing twelve months (TTM) was €21M. Compared to the same quarter last year (YoY), quarterly revenue grew by -16.90%, and quarterly earnings saw a YoY growth of N/A.

How much of AVTX stock is held by insiders and institutions?

Wondering who owns Avantium N.V stock? Company insiders (like executives and directors) hold about 7.65% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 5.65%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.